Board appointment at FoldRx Pharmaceuticals
This article was originally published in Scrip
Executive Summary
Dr Georges Gemayel has been appointed executive chairman of FoldRx Pharmaceuticals' board of directors. He also serves on the boards of Adolor and Syndexa. Dr Gemayel served as president, CEO and director of Altus Pharmaceuticals from June 2008 until November 2009. Before that, he was executive vice-president of therapeutics and biosurgery at Genzyme. FoldRx is a development and discovery company focusing on first-in-class, disease-modifying small-molecule therapeutics to treat diseases of protein misfolding and aggregation (amyloidosis).